Cargando…
Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study
INTRODUCTION: Exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) is limited. This analysis modelled behavioural trajectories following treatment for recent HCV and assessed reinfection. METHODS: Participants treated for recent HCV in an international...
Autores principales: | , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483502/ https://www.ncbi.nlm.nih.gov/pubmed/37675828 http://dx.doi.org/10.1002/jia2.26168 |
_version_ | 1785102400034439168 |
---|---|
author | Carson, Joanne M. Barbieri, Sebastiano Cunningham, Evan Mao, Eric van der Valk, Marc Rockstroh, Jürgen K. Hellard, Margaret Kim, Arthur Bhagani, Sanjay Feld, Jordan J. Gane, Ed Thurnheer, Maria C. Bruneau, Julie Tu, Elise Dore, Gregory J. Matthews, Gail V. Martinello, Marianne |
author_facet | Carson, Joanne M. Barbieri, Sebastiano Cunningham, Evan Mao, Eric van der Valk, Marc Rockstroh, Jürgen K. Hellard, Margaret Kim, Arthur Bhagani, Sanjay Feld, Jordan J. Gane, Ed Thurnheer, Maria C. Bruneau, Julie Tu, Elise Dore, Gregory J. Matthews, Gail V. Martinello, Marianne |
author_sort | Carson, Joanne M. |
collection | PubMed |
description | INTRODUCTION: Exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) is limited. This analysis modelled behavioural trajectories following treatment for recent HCV and assessed reinfection. METHODS: Participants treated for recent HCV in an international trial (enrolled 2017–2019) were followed at 3‐monthly intervals for up to 2 years to assess longitudinal behaviours. Population‐averaged changes were assessed using generalized estimating equations. Distinct behavioural trajectories were identified using group‐based trajectory modelling. HCV reinfection incidence was calculated using person‐years (PY) of observation. RESULTS: During the follow‐up of 212 participants (84% gay and bisexual men [GBM]; 69% HIV; 26% current injecting drug use [IDU]), behavioural trajectories for IDU and stimulant use (past month) did not change. However, population‐averaged decreases in the likelihood of daily IDU (adjusted odds ratio [AOR] 0.83; 95% CI 0.72, 0.95) and opioid use (AOR 0.84; 95% CI 0.75, 0.93) were observed. Among GBM, behavioural trajectories for chemsex did not change. Population‐averaged decreases in condomless anal intercourse with casual male partners (CAI‐CMP) (AOR 0.95; 95% CI 0.90, 0.99) and group‐sex (AOR 0.86; 95% CI 0.80, 0.93) were observed, but masked distinct trajectories. While a proportion had a decreased probability of CAI‐CMP (23%) and group‐sex (59%) post‐treatment, a substantial proportion retained a high probability of these behaviours. High HCV reinfection incidence was observed for the sustained high probability IDU (33.0/100 PY; 95% CI 17.7, 61.3) and chemsex (23.3/100 PY; 95% CI 14.5, 37.5) trajectories. CONCLUSIONS: Limited sexual and drug use behavioural change was observed following treatment for recent HCV, supporting access to surveillance and (re)treatment. |
format | Online Article Text |
id | pubmed-10483502 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | John Wiley and Sons Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104835022023-09-08 Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study Carson, Joanne M. Barbieri, Sebastiano Cunningham, Evan Mao, Eric van der Valk, Marc Rockstroh, Jürgen K. Hellard, Margaret Kim, Arthur Bhagani, Sanjay Feld, Jordan J. Gane, Ed Thurnheer, Maria C. Bruneau, Julie Tu, Elise Dore, Gregory J. Matthews, Gail V. Martinello, Marianne J Int AIDS Soc Research Articles INTRODUCTION: Exploration of sexual and drug use behaviours following treatment for recent hepatitis C virus (HCV) is limited. This analysis modelled behavioural trajectories following treatment for recent HCV and assessed reinfection. METHODS: Participants treated for recent HCV in an international trial (enrolled 2017–2019) were followed at 3‐monthly intervals for up to 2 years to assess longitudinal behaviours. Population‐averaged changes were assessed using generalized estimating equations. Distinct behavioural trajectories were identified using group‐based trajectory modelling. HCV reinfection incidence was calculated using person‐years (PY) of observation. RESULTS: During the follow‐up of 212 participants (84% gay and bisexual men [GBM]; 69% HIV; 26% current injecting drug use [IDU]), behavioural trajectories for IDU and stimulant use (past month) did not change. However, population‐averaged decreases in the likelihood of daily IDU (adjusted odds ratio [AOR] 0.83; 95% CI 0.72, 0.95) and opioid use (AOR 0.84; 95% CI 0.75, 0.93) were observed. Among GBM, behavioural trajectories for chemsex did not change. Population‐averaged decreases in condomless anal intercourse with casual male partners (CAI‐CMP) (AOR 0.95; 95% CI 0.90, 0.99) and group‐sex (AOR 0.86; 95% CI 0.80, 0.93) were observed, but masked distinct trajectories. While a proportion had a decreased probability of CAI‐CMP (23%) and group‐sex (59%) post‐treatment, a substantial proportion retained a high probability of these behaviours. High HCV reinfection incidence was observed for the sustained high probability IDU (33.0/100 PY; 95% CI 17.7, 61.3) and chemsex (23.3/100 PY; 95% CI 14.5, 37.5) trajectories. CONCLUSIONS: Limited sexual and drug use behavioural change was observed following treatment for recent HCV, supporting access to surveillance and (re)treatment. John Wiley and Sons Inc. 2023-09-07 /pmc/articles/PMC10483502/ /pubmed/37675828 http://dx.doi.org/10.1002/jia2.26168 Text en © 2023 The Authors. Journal of the International AIDS Society published by John Wiley & Sons Ltd on behalf of the International AIDS Society. https://creativecommons.org/licenses/by/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Research Articles Carson, Joanne M. Barbieri, Sebastiano Cunningham, Evan Mao, Eric van der Valk, Marc Rockstroh, Jürgen K. Hellard, Margaret Kim, Arthur Bhagani, Sanjay Feld, Jordan J. Gane, Ed Thurnheer, Maria C. Bruneau, Julie Tu, Elise Dore, Gregory J. Matthews, Gail V. Martinello, Marianne Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study |
title | Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study |
title_full | Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study |
title_fullStr | Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study |
title_full_unstemmed | Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study |
title_short | Sexual and drug use risk behaviour trajectories among people treated for recent HCV infection: the REACT study |
title_sort | sexual and drug use risk behaviour trajectories among people treated for recent hcv infection: the react study |
topic | Research Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10483502/ https://www.ncbi.nlm.nih.gov/pubmed/37675828 http://dx.doi.org/10.1002/jia2.26168 |
work_keys_str_mv | AT carsonjoannem sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT barbierisebastiano sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT cunninghamevan sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT maoeric sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT vandervalkmarc sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT rockstrohjurgenk sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT hellardmargaret sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT kimarthur sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT bhaganisanjay sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT feldjordanj sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT ganeed sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT thurnheermariac sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT bruneaujulie sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT tuelise sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT doregregoryj sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT matthewsgailv sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT martinellomarianne sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy AT sexualanddruguseriskbehaviourtrajectoriesamongpeopletreatedforrecenthcvinfectionthereactstudy |